# Using Phenazopyridine for In-office Cystoscopy

> **NCT02715648** · NA · UNKNOWN · sponsor: **Boston Urogynecology Associates** · enrollment: 94 (estimated)

## Conditions studied

- Cystoscopy
- Phenazopyridine

## Interventions

- **DRUG:** Phenazopyridine

## Key facts

- **NCT ID:** NCT02715648
- **Lead sponsor:** Boston Urogynecology Associates
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2020-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02715648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02715648, "Using Phenazopyridine for In-office Cystoscopy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02715648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*